What is the Hims Weight Loss program?
Hims Weight Loss is the medical weight-management program from Hims & Hers Health, a US telehealth company. When people search for Hims Weight Loss, they usually want to understand how the program uses GLP-1 medications like semaglutide, who qualifies, what it costs, and how the compounding and regulatory picture affects what is actually available. This page is an independent, educational overview intended to help you make sense of all of that before you commit.
One thing up front: this is general information, not medical advice. GLP-1 medications are powerful drugs with real side effects, contraindications, and an evolving regulatory status. Anything here should be confirmed with a licensed clinician who can evaluate your specific health situation.
The program pairs an online clinical process with prescription medication and lifestyle support. It has historically centered on GLP-1 receptor agonists, most notably semaglutide, and has at various points offered compounded formulations, oral kits, and branded options. Because this category has been reshaped by FDA shortage decisions and the broader relationship between telehealth companies and drug manufacturers, the specifics change more often than in most health categories. That volatility is a core theme of this guide.
How do GLP-1 medications work for weight loss?
GLP-1 stands for glucagon-like peptide-1, a hormone your gut releases after eating. GLP-1 receptor agonists — the drug class that includes semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (a dual-action agent in Mounjaro and Zepbound) — mimic and amplify that hormone’s effects. In practical terms they tend to:
- Reduce appetite and hunger signals
- Slow stomach emptying, so you feel full longer
- Help lower food intake, which can drive weight loss over time
In clinical trials of branded GLP-1 medications, many participants lost a clinically meaningful percentage of body weight when the drug was combined with diet and activity changes. Results vary considerably between individuals, and weight tends to return if the medication is stopped and lifestyle changes are not maintained. GLP-1s are tools that work alongside behavior change, not magic bullets.
Most GLP-1 medications for weight loss are injectable, given as a once-weekly self-injection with a small needle. That is the format with the strongest evidence base. Oral options exist and continue to develop, but the depth of supporting data differs by product.
Why GLP-1s changed the weight-loss conversation
For decades, medical weight loss relied on modestly effective drugs and the hard, often disappointing work of diet and exercise alone. GLP-1 receptor agonists shifted expectations because the average weight loss seen in trials was substantially larger than earlier medications delivered. That is a big part of why demand surged and why telehealth companies, including Hims, built programs around them. It is also why it is worth keeping perspective: trial averages are not individual guarantees, the medications generally need to be continued to maintain their effect, and they work best alongside — not instead of — dietary and activity changes. Understanding a GLP-1 as a long-term tool rather than a quick fix leads to more realistic decisions.
What does Hims actually offer?
Hims’ weight-loss lineup has included several elements, though the exact mix has shifted:
| Format | What it is | Notes |
|---|---|---|
| Compounded semaglutide (injectable) | Pharmacy-compounded GLP-1 | Not FDA-approved as a finished product; availability tied to shortage rules |
| Branded GLP-1 options | Manufacturer-made products | Availability and access have varied over time |
| Oral kits | Non-injectable formulations | Evidence base varies by product; ask what’s included |
| Lifestyle and support | Guidance, check-ins | Wraps around the medication |
The most consequential distinction is between compounded and branded medication. Branded GLP-1s (like Wegovy) are FDA-approved finished products made by their manufacturer. Compounded semaglutide is prepared by compounding pharmacies and is not FDA-approved as a finished product — a point we return to below. Our Hims Wegovy page covers the branded and tirzepatide side in more depth, including how semaglutide and tirzepatide compare.
For firsthand-style perspectives on results and complaints, see Hims Weight Loss Reviews.
The compounding and regulatory context
This is the part that trips people up, so it is worth being careful and clear.
Compounded semaglutide is not an FDA-approved product. Compounding pharmacies can legally prepare certain medications, and during periods when the FDA officially lists a drug as being in shortage, compounders have broader latitude to make versions of it. Much of the availability of compounded GLP-1s through telehealth was tied to semaglutide and tirzepatide being on the FDA shortage list.
When the FDA determines a shortage has resolved, that latitude narrows, and compounded versions of the drug can become restricted or unavailable. This is exactly what drove widely reported shifts in the telehealth GLP-1 market: as shortage designations changed, companies had to adjust what they offered. The relationship between Hims & Hers and Novo Nordisk, the maker of Wegovy and Ozempic, has also been a moving piece of this story, at times involving branded access arrangements and at times public friction.
The practical takeaways for you:
- Compounded semaglutide is not reviewed by the FDA for safety, effectiveness, or manufacturing quality the way approved drugs are.
- Availability of compounded GLP-1s can change quickly with regulatory decisions.
- What Hims offers today may differ from what it offered a few months ago or will offer in the future.
None of this makes compounded medication automatically unsafe, but it does mean the usual FDA safety net does not apply in the same way, and that is a genuine consideration a clinician should discuss with you. Because GLP-1s are also central to Hims & Hers’ business growth story, this regulatory backdrop even affects the company financially — something covered on our Hims Stock page.
Who is eligible for Hims Weight Loss?
Eligibility is a clinical decision. A licensed clinician reviews your intake information and considers factors commonly used in GLP-1 prescribing, such as body mass index (BMI) and related health conditions. Broadly, medical weight-loss programs tend to consider candidates who meet certain BMI thresholds, or lower thresholds when weight-related conditions are present, mirroring the standards used for approved GLP-1 drugs.
Not everyone qualifies. Clinicians may decline if a GLP-1 appears unsafe or inappropriate — for example, with certain personal or family histories, specific thyroid cancer risk factors, pancreatitis history, pregnancy, or interacting conditions. The honesty and completeness of your online intake directly shapes whether the clinician can make a sound decision, which is another reason accurate answers matter.
Oral vs injectable: which does Hims offer?
Hims has offered both injectable GLP-1 medication and oral kits at various times.
- Injectable GLP-1 is typically a once-weekly self-injection. This is the most studied route for weight loss and what the major clinical trials used.
- Oral kits are non-injectable formulations. Some people strongly prefer avoiding needles. The trade-off is that the evidence base and the specific formulation matter a great deal, and not all oral products are equivalent to the injectable versions studied in trials.
If needle avoidance is important to you, an oral route may be appealing, but it is fair to ask exactly what the product contains, what dose, and what data supports it. A clinician can help weigh convenience against evidence.
How does the Hims online process work?
The Hims weight-loss flow follows the general telehealth model. You create an account and complete a detailed health questionnaire covering weight history, medical conditions, current medications, and relevant factors. A licensed clinician reviews your responses to judge eligibility and safety. If treatment is appropriate, a prescription can be issued and medication dispensed and shipped, typically on a recurring plan with periodic check-ins. Some programs may request additional information, such as recent lab values or measurements, depending on clinical judgment and state rules. Because GLP-1s require ongoing dose titration and monitoring, the program is designed around continuity rather than a one-off purchase. As always, a prescription is required, and honest, complete intake information is what allows the clinician to make a sound decision.
What are the side effects and risks?
GLP-1 medications share a recognizable side effect profile, most of it gastrointestinal:
- Nausea (very common, especially early)
- Vomiting
- Diarrhea or constipation
- Reduced appetite and early fullness
These effects are often strongest when starting the medication or increasing the dose, and many people find they ease over time. Doses are usually titrated up gradually to improve tolerability. Less common but serious risks include pancreatitis, gallbladder problems, and specific contraindications related to certain thyroid tumors and personal or family history. There are also questions about muscle loss and nutrition during rapid weight loss that a clinician can help you manage.
Because compounded products are not FDA-reviewed, there is an added layer of uncertainty about consistency and quality with those specific formulations. This is precisely the kind of risk-benefit conversation that belongs with a clinician, not a website — the “not medical advice” note here is meant sincerely.
There are also important contraindications. GLP-1 medications are generally not recommended for people with a personal or family history of medullary thyroid carcinoma or a condition called multiple endocrine neoplasia syndrome type 2, and they are not for use in pregnancy. People with a history of pancreatitis, gallbladder disease, or certain gastrointestinal conditions need careful evaluation. This is why the clinical screening step is more than a formality: a thorough intake is meant to catch situations where a GLP-1 could be unsafe, and it only works if your answers are complete and accurate.
What does Hims Weight Loss cost?
We avoid quoting fixed prices because the program uses plan- and product-based pricing that varies by dose and changes over time. In general:
- Compounded options have often been positioned as more affordable than branded GLP-1s.
- Branded GLP-1 medications can be expensive, sometimes very expensive, without insurance coverage.
- Insurance frequently does not cover GLP-1s for weight loss, though this varies by plan and is evolving.
When comparing, look at the full monthly cost, including any consultation or membership fees, and consider how long you might stay on the medication. Weigh Hims against other telehealth providers, in-person clinics, and — where you qualify and can access it — insurance-covered branded medication, which may be cheaper net of coverage. Our Hims Reviews hub and the Hims Weight Loss Reviews page discuss value and user experience further.
Is Hims Weight Loss right for you?
Hims Weight Loss may suit people who want a convenient, private, online route to medical weight management and who understand the trade-offs of compounded medication and subscription pricing. It may be less suitable if you prefer in-person monitoring, have complex medical history, want only FDA-approved finished products, or can access branded GLP-1s more affordably through insurance.
A sensible approach is to treat the medication as one part of a broader plan that includes diet, activity, and monitoring, and to keep in mind that this market changes quickly. Confirm current offerings, pricing, and regulatory status directly, and make the final call with a licensed clinician who knows your full health picture.
What questions should you ask before starting?
Before committing to a weight-loss program, it helps to have clear answers to a few practical questions:
- What exactly am I being prescribed — branded or compounded, and at what dose?
- What is the total monthly cost, including any consultation or membership fees, and how might it change as the dose increases?
- What happens if availability changes due to regulatory shifts — will my treatment be interrupted?
- How is my progress monitored, and how do I reach a clinician if I have side effects?
- What is the plan if I want to stop, and what is known about weight regain afterward?
Getting straight answers to these before you start tends to prevent the most common frustrations reported by users, many of which center on cost, cancellation, and disruption rather than the medication itself. The Hims Weight Loss Reviews page explores those real-world experiences in more detail.
For related reading, explore Hims Weight Loss Reviews, Hims Wegovy, the broader Hims Reviews hub, and — for the business angle on GLP-1 as a growth driver — Hims Stock.